Citadel Advisors
CRGX

Citadel Advisors’s CARGO Therapeutics CRGX Stock Holding History

Citadel Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,400
Closed -$183K – 12928
2025
Q2 		$183K Buy
44,400
+5,700
+15% +$24.4K ﹤0.01% 10760
2025
Q1 		$158K Buy
+38,700
New +$259K ﹤0.01% 10802

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's CRGX Position: Q3 2025 in Review

Citadel Advisors sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 507,418 shares — an estimated $2.09M sold.

Citadel Advisors first reported a position in CRGX in Q4 2023 and held it in 3 quarters. The position peaked at $4.56M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Citadel Advisors reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 507,418 CARGO Therapeutics shares in Q3 2025, an estimated $2.09M.
  • Citadel Advisors first reported a position in CARGO Therapeutics in Q4 2023 and held it in 3 quarters.
  • Citadel Advisors's CARGO Therapeutics position peaked at $4.56M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.